Drug Approval Package
-
Wellbutrin Immediate Release Tablets, Wellbutrin SR (Bupropion Hydrochloride) Sustained Release Tablets & XL Extended Release Tablets
Company: GlaxoSmithKline
Application No.: 018644s027s028, 020358s031s032 & 021515s006s007
Approval Date: 05/27/2004
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
Date created: June 22, 2007
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-